Healthcare and Technology news
50.9K views | +5 today
Healthcare and Technology news
Your new post is loading...
Your new post is loading...!

Cerner big data platform gets new client

Cerner big data platform gets new client | Healthcare and Technology news |

Truman Medical Centers and the University of Missouri-Kansas City's Center for Health Insights have teamed up on a new initiative that will harness data from electronic medical records, de-identifying it and digesting it into a database that can help inform better care decisions.

Both organizations will partner with EMR giant Cerner to leverage its Health Facts data warehouse platform to drive the analytics initiative. Health Facts extracts data from both clinical and financial IT systems, de-identifies the data, standardizes terms through mapping to common nomenclature and has the ability to create adverse drug events and outcomes reports.

The platform, as Cerner officials described, will allow the two-hospital TMC to use its current clinical and financial data and transform it into a usable form that can be leveraged to improve patient safety and care outcomes. What's more, TMC officials anticipate the data analysis can also be used to reduce specific health disparities and reduce costs for certain procedures.

Specifically, with the platform TMC officials will be able to use the generated reports and compare one's organization's performance with other clients who use the warehouse. The warehouse already includes millions of EMR records from inpatient, ED and outpatient visits from patients nationwide.

"The centerpiece of this partnership provides tools to accelerate clinical and translational research and ultimately provide better health outcomes," said Lawrence Dreyfus, UMKC vice chancellor for Research and Economic Development, in a Feb. 18 press statement. "We couldn't be more excited about the prospects that this partnership holds for healthcare decisions that ultimately improve care and reduce costs."

No comment yet.!

BREAKING: Cerner to Buy Siemens Health IT Division for $1.3 Billion; EXCLUSIVE: Cerner President Speaks First to HCI

BREAKING: Cerner to Buy Siemens Health IT Division for $1.3 Billion; EXCLUSIVE: Cerner President Speaks First to HCI | Healthcare and Technology news |
In one of the biggest deals in healthcare IT history, the Kansas City, Mo.-based Cerner Corporation is acquiring Siemens healthcare information technology business for $1.3 billion.

The deal will make Cerner the top revenue-earning company among U.S. electronic health record (EHR) vendors. Cerner and Siemens AG agreed upon the deal that will combine R&D, knowledgeable resources, and complementary client bases. Specifically, Cerner says the combined company will have 20,000 associates in more than 30 countries, 18,000 client facilities, including some of the largest health care organizations in their respective countries, $650 million of annual R&D investment, and a projected $4.5 billion of annual revenue.

According to an industry source, the deal is a defensive play against the Verona, Wisc.-based Epic, which has won a significant share of new hospital and health systems’ EHR contracts over the past few years. The deal with Siemens would add to Cerner’s market share and customer base.

However, in an exclusive interview with Healthcare Informatics, Cerner president Zane Burke said that was not the case at all. “There are lots of ways to actually figure out who [the top revenue producer is] in this marketplace, and actually, Epic is not the largest as of today—another competitor of ours probably is,” Burke said. “Cerner is doing incredibly well today. We didn’t need to make an acquisition, nor were we even looking for one,” he added.

Burke said that the fit with Siemens was “great,” and that Cerner is looking forward to adding some of Siemens’ additional skill-sets such as revenue cycle and connectivity through the clinical workflow process. Also noteworthy, Burke added that the RIS/PACS pieces of Siemens would not be part of the merger and would remain with Siemens separately.

Cerner says that the acquisition will have no effect on support for Siemens Health Services core platforms and current implementations will continue. The company says it plans to support and advance the Soarian platform for at least the next decade.“This means interoperability will start at home, and while we have been at that for quite a while, this is one more way to do that,” said Burke.

Burke said the main significance of the merger, in regards to the health IT industry, is getting its client base the tools they need to succeed in the ever-changing healthcare environment. “I have never seen the need for better or more efficient tools than our clients need today. We want to be able to drive innovation in a better way, advance that medical practice, and then for us, it does create some complementary global elements. There are countries we are strong in as well as countries they are strong in, and that’s a very positive thing for healthcare,” Burke said.

The deal had been reported as rumor on Twitter, by Healthcare Informatics and others, a few weeks ago for $1.2 billion. According to the industry insider, the two sides argued over the amount for a few weeks, with Cerner wanting to buy the division at the $1.2 billion price and Siemens wanting to sell it at $1.4 billion. They met in the middle and a deal was struck.

According to Burke, the two sides have been talking for about seven months and “a deal really come together in the last 30 days. As far as we knew, there were no other bidders involved. This was just about us and them,” Burke said.

Earlier this summer, Siemens was rumored to want out of the health IT business to focus on their energy and industrial businesses. In a statement, Hermann Requardt, CEO Siemens Healthcare said: “An increasing number of country-specific reruirements, many resulting from US healthcare reform, make it increasingly challenging to achieve sufficient scale effects. Going forward we will focus on the development of information systems that support our businesses in laboratory diagnostics as well as imaging and therapy.”

The transaction is expected to be more than $0.15 accretive to Cerner’s non-GAAP diluted EPS in 2015, and more than $0.25 accretive in 2016.
No comment yet.